Literature DB >> 7488205

Overexpression of prostacyclin synthase inhibits growth of vascular smooth muscle cells.

S Hara1, R Morishita, Y Tone, C Yokoyama, H Inoue, Y Kaneda, T Ogihara, T Tanabe.   

Abstract

To define the local effects of prostacyclin (PGI2) on the growth of vascular smooth muscle cells (VSMC), we transfected VSMC with an expression vector harboring the cDNA for PGI2 synthase (PGIS), which catalyzes the rearrangement of prostaglandin H2 to PGI2. Transfection of the human PGIS cDNA into rat VSMC did not affect DNA synthesis under serum-free basal conditions, but it increased PGI2 synthesis and decreased DNA synthesis under serum-stimulated conditions (in the presence of 1 or 5% fetal calf serum). These results demonstrated that locally synthesized PGI2 can exert autocrine and/or paracrine inhibitory effects on VSMC growth. It was also suggested that in vivo transfer of PGIS gene may be useful for the gene therapy for vascular disease such as neointimal hyperplasia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7488205     DOI: 10.1006/bbrc.1995.2701

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Role of COX-2 in the bioactivation of methylenedianiline and in its proliferative effects in vascular smooth muscle cells.

Authors:  Valeria Y Hebert; Brandon Chad Jones; Randy C Mifflin; Tammy R Dugas
Journal:  Cardiovasc Toxicol       Date:  2011-12       Impact factor: 3.231

Review 2.  Gene therapy for the prevention of vein graft disease.

Authors:  Kevin W Southerland; Sarah B Frazier; Dawn E Bowles; Carmelo A Milano; Christopher D Kontos
Journal:  Transl Res       Date:  2012-12-27       Impact factor: 7.012

3.  Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice.

Authors:  D Praticò; C Tillmann; Z B Zhang; H Li; G A FitzGerald
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

4.  Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension.

Authors:  M W Geraci; B Gao; D C Shepherd; M D Moore; J Y Westcott; K A Fagan; L A Alger; R M Tuder; N F Voelkel
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

5.  PPARdelta inhibits IL-1beta-stimulated proliferation and migration of vascular smooth muscle cells via up-regulation of IL-1Ra.

Authors:  H J Kim; M Y Kim; J S Hwang; H J Kim; J H Lee; K C Chang; J-H Kim; C W Han; J-H Kim; H G Seo
Journal:  Cell Mol Life Sci       Date:  2010-03-10       Impact factor: 9.261

6.  Integrative genomics identifies DSCR1 (RCAN1) as a novel NFAT-dependent mediator of phenotypic modulation in vascular smooth muscle cells.

Authors:  Monica Y Lee; Sean M Garvey; Alex S Baras; Julia A Lemmon; Maria F Gomez; Pamela D Schoppee Bortz; Guenter Daum; Renee C LeBoeuf; Brian R Wamhoff
Journal:  Hum Mol Genet       Date:  2009-11-19       Impact factor: 6.150

Review 7.  Sorting out the functional role(s) of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) in cell proliferation and cancer.

Authors:  Jeffrey M Peters; Frank J Gonzalez
Journal:  Biochim Biophys Acta       Date:  2009-06-06

Review 8.  Pulmonary hypertension: work in progress.

Authors:  Paul D Boyce; Aaron B Waxman
Journal:  J Nucl Cardiol       Date:  2003 Jul-Aug       Impact factor: 5.952

9.  Relationship between serum levels of triglycerides and vascular inflammation, measured as COX-2, in arteries from diabetic patients: a translational study.

Authors:  Antonio Gordillo-Moscoso; Emilio Ruiz; Manuel Carnero; Fernando Reguillo; Enrique Rodriguez; Teresa Tejerina; Santiago Redondo
Journal:  Lipids Health Dis       Date:  2013-05-03       Impact factor: 3.876

Review 10.  Pulmonary hypertension associated with COPD.

Authors:  Jean Elwing; Ralph J Panos
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.